Abbott Laboratories (ABT)
$83.76 0.02 (0.02%)
18:30 EST ABT Stock Quote Delayed 15 Minutes
Previous Close $83.76
Market Cap 146.85B
PE Ratio 398.86
Volume (Avg. Vol.) 3.14M
Day's Range 83.31 - 83.90
52-Week Range 65.44 - 88.76
Dividend & Yield 1.12 (1.34%)
ABT Stock Predictions, Articles, and Abbott Laboratories News
- From InvestorPlace
- From the Web
Adobe, Netflix, ServiceNow, Workday and Abbott Labs were our top stock trades from Wednesday. Here's a look at the charts.
The stock charts of MAC, ABT and MSCI are positioned to start the new trading week in clearly defined situations. Here are levels to watch.
Abbott Laboratories earnings for the company's second quarter of 2019 has ABT stock heading higher Wednesday on positive results.
Netflix, IBM, Abbott Labs, Domino's Pizza and the IBB ETF were our top stock trades to watch for Thursday, the last trading day this week.
Abbott Laboratories earnings for the first quarter of 2019 have ABT stock down on Wednesday despite it beating estimates.
Abbott Labs (ABT) stock was down more than 2% on Wednesday despite the fact that the company's fourth-quarter earnings reached expectations.
IBM, Abbott Labs, Papa John's, Starbucks and Disney round out our must-see stock charts for Thursday. Here's why.
Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.
These consumer stocks offer generous, growing dividends and should return to a growth trajectory based on new business lines.
The stock charts of INCY, ABT and SLB are set to end the week on a more definitive, trade-worthy footing than most other names.
ABT stock was down on Wednesday after the healthcare company released its earnings report for the third quarter of the year.
The short-term nature of the stock markets makes it hard for companies to think bigger picture -- but these seven best long-term stocks do.
There are dividend stocks, and then there are dividend aristocrats. These ten names are the income producers you rarely have to worry about.
We take a closer look at 10 stocks RBC Capital has pinpointed as the leaders and laggards of the future. These are the stocks that are set to outperform in 2025, but also the stocks facing the biggest risks from our ever-changing society.
Abbott Laboratories (ABT) stock was up on Wednesday following the release of its earnings report for the second quarter of 2018.
Stock charts of United Technologies, Abbott Laboratories and Leggett & Platt have earned a closer look as bullish trading prospects this morning.
From Talk Markets
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!